323 related articles for article (PubMed ID: 33243126)
1. How Does the Covıd-19 Pandemıc Affect the Target 90-90-90?
Karaosmanoglu HK
Curr HIV Res; 2021; 19(2):103-105. PubMed ID: 33243126
[TBL] [Abstract][Full Text] [Related]
2. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
[TBL] [Abstract][Full Text] [Related]
3. Modeling the epidemiological impact of the UNAIDS 2025 targets to end AIDS as a public health threat by 2030.
Stover J; Glaubius R; Teng Y; Kelly S; Brown T; Hallett TB; Revill P; Bärnighausen T; Phillips AN; Fontaine C; Frescura L; Izazola-Licea JA; Semini I; Godfrey-Faussett P; De Lay PR; Benzaken AS; Ghys PD
PLoS Med; 2021 Oct; 18(10):e1003831. PubMed ID: 34662333
[TBL] [Abstract][Full Text] [Related]
4. Trend of HIV/AIDS for the last 26 years and predicting achievement of the 90-90-90 HIV prevention targets by 2020 in Ethiopia: a time series analysis.
Girum T; Wasie A; Worku A
BMC Infect Dis; 2018 Jul; 18(1):320. PubMed ID: 29996776
[TBL] [Abstract][Full Text] [Related]
5. Achieving the 95 95 95 targets for all: A pathway to ending AIDS.
Frescura L; Godfrey-Faussett P; Feizzadeh A A; El-Sadr W; Syarif O; Ghys PD;
PLoS One; 2022; 17(8):e0272405. PubMed ID: 35925943
[TBL] [Abstract][Full Text] [Related]
6. Stakeholder efforts to mitigate antiretroviral therapy interruption among people living with HIV during the COVID-19 pandemic in China: a qualitative study.
Sun Y; Zhan Y; Li H; Yuan T; Gao Y; Liang B; Feng A; Li P; Zheng W; Fitzpatrick T; Wu D; Zhai X; Zou H
J Int AIDS Soc; 2021 Sep; 24(9):e25781. PubMed ID: 34473409
[TBL] [Abstract][Full Text] [Related]
7. Population-level impact of an accelerated HIV response plan to reach the UNAIDS 90-90-90 target in Côte d'Ivoire: Insights from mathematical modeling.
Maheu-Giroux M; Vesga JF; Diabaté S; Alary M; Baral S; Diouf D; Abo K; Boily MC
PLoS Med; 2017 Jun; 14(6):e1002321. PubMed ID: 28617810
[TBL] [Abstract][Full Text] [Related]
8. Poor adherence to antiretroviral therapy among adult people living with HIV initiated during the COVID-19 epidemic waves - observations at the University Teaching Hospital in Lusaka, Zambia.
Kafwanka P; Nalule FM; Michelo C
Front Public Health; 2023; 11():1094214. PubMed ID: 36992897
[TBL] [Abstract][Full Text] [Related]
9. Sweden, the first country to achieve the Joint United Nations Programme on HIV/AIDS (UNAIDS)/World Health Organization (WHO) 90-90-90 continuum of HIV care targets.
Gisslén M; Svedhem V; Lindborg L; Flamholc L; Norrgren H; Wendahl S; Axelsson M; Sönnerborg A
HIV Med; 2017 Apr; 18(4):305-307. PubMed ID: 27535540
[TBL] [Abstract][Full Text] [Related]
10. Achieving the UNAIDS 95-95-95 treatment target by 2025 in Ghana: a myth or a reality?
Boakye DS; Adjorlolo S
Glob Health Action; 2023 Dec; 16(1):2271708. PubMed ID: 37921654
[TBL] [Abstract][Full Text] [Related]
11. From crisis to crisis: impacts of the COVID-19 pandemic on people living with HIV and HIV/AIDS service organizations in Indiana.
MacNeill JJ; Linnes JC; Hubach RD; Rodriguez NM
BMC Health Serv Res; 2022 May; 22(1):622. PubMed ID: 35534824
[TBL] [Abstract][Full Text] [Related]
12. Impact and Cost of Scaling Up Voluntary Medical Male Circumcision for HIV Prevention in the Context of the New 90-90-90 HIV Treatment Targets.
Kripke K; Reed J; Hankins C; Smiley G; Laube C; Njeuhmeli E
PLoS One; 2016; 11(10):e0155734. PubMed ID: 27783681
[TBL] [Abstract][Full Text] [Related]
13. Thirty years of HIV and AIDS: future challenges and opportunities.
Dieffenbach CW; Fauci AS
Ann Intern Med; 2011 Jun; 154(11):766-71. PubMed ID: 21628350
[TBL] [Abstract][Full Text] [Related]
14. Barriers to access to antiretroviral therapy by people living with HIV in an indonesian remote district during the COVID-19 pandemic: a qualitative study.
Fauk NK; Gesesew HA; Seran AL; Ward PR
BMC Infect Dis; 2023 May; 23(1):296. PubMed ID: 37147599
[TBL] [Abstract][Full Text] [Related]
15. Incidence, survival time and associated factors of virological failure among adult HIV/AIDS patients on first line antiretroviral therapy in St. Paul's Hospital Millennium Medical College-A retrospective cohort study.
Andarge DE; Hailu HE; Menna T
PLoS One; 2022; 17(10):e0275204. PubMed ID: 36227886
[TBL] [Abstract][Full Text] [Related]
16. Ethical and programmatic challenges in antiretroviral scaling-up in Malawi: challenges in meeting the World Health Organization's "Treating 3 million by 2005" initiative goals.
Muula AS
Croat Med J; 2004 Aug; 45(4):415-21. PubMed ID: 15311413
[TBL] [Abstract][Full Text] [Related]
17. [Community organizations and fighting STDs, HIV and AIDS in Montreal: lessons for sub-Saharan Africa].
Agonnoude MT; Mesenge C
Sante; 2010; 20(2):116-24. PubMed ID: 20685643
[TBL] [Abstract][Full Text] [Related]
18. Progress in Reversing the HIV Epidemic through Intensified Access to Antiretroviral Therapy: Results from a Nationally Representative Population-Based Survey in Kenya, 2012.
Kim AA; Mukui I; N'gan'ga L; Katana A; Koros D; Wamicwe J; De Cock KM;
PLoS One; 2016; 11(3):e0148068. PubMed ID: 26930291
[TBL] [Abstract][Full Text] [Related]
19. Voluntary Counseling and Testing, Antiretroviral Therapy Access, and HIV-Related Stigma: Global Progress and Challenges.
Armstrong-Mensah EA; Tetteh AK; Ofori E; Ekhosuehi O
Int J Environ Res Public Health; 2022 May; 19(11):. PubMed ID: 35682181
[TBL] [Abstract][Full Text] [Related]
20. Pediatric HIV Case Identification Across 22 PEPFAR-Supported Countries During the COVID-19 Pandemic, October 2019-September 2020.
Traub AM; Medley A; Gross J; Sloan M; Amzel A; Gleason MM; Fernando NB; Wong V; Grillo MP; Wolf HT; Al-Samarrai T; Frawley A; Segwabe M; Motswere C; Baramperanye E; Nzima V; Mange Mayer M; Balachandra S; N'siesi FX; Longuma HO; Nyembo P; Mazibuko S; Tilahun T; Teferi W; Desinor O; Reginald JL; Simiyu T; Nyabiage L; Mirembe J; Ts'oeu M; Zomba G; Nyangulu M; Wate A; Greenberg Cowan J; Mali D; Pietersen I; Ogundehin D; Onotu D; Ikpeazu A; Niyonsaba E; Bamwesigye J; Mabasa H; Kindra G; Bunga S; Rwegerera F; Machage E; King'ori G; Calnan J; Nazziwa E; Lingenda G; Musokotwane K; Bulaya-Tembo R; Maphosa T; Srivastava M
MMWR Morb Mortal Wkly Rep; 2022 Jul; 71(28):894-898. PubMed ID: 35834422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
